Carr Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $975K | Buy |
5,252
+40
| +0.8% | +$7.43K | 0.29% | 66 |
|
|
2025
Q1 | $1.09M | Buy |
5,212
+156
| +3% | +$32.7K | 0.36% | 53 |
|
|
2024
Q4 | $899K | Sell |
5,056
-218
| -4% | -$38.7K | 0.28% | 64 |
|
|
2024
Q3 | $1.04M | Buy |
5,274
+56
| +1% | +$11.1K | 0.31% | 59 |
|
|
2024
Q2 | $895K | Buy |
5,218
+145
| +3% | +$24.9K | 0.28% | 68 |
|
|
2024
Q1 | $924K | Sell |
5,073
-325
| -6% | -$59.2K | 0.31% | 63 |
|
|
2023
Q4 | $836K | Sell |
5,398
-93
| -2% | -$14.4K | 0.31% | 62 |
|
|
2023
Q3 | $776K | Buy |
5,491
+937
| +21% | +$133K | 0.31% | 63 |
|
|
2023
Q2 | $614K | Buy |
4,554
+469
| +11% | +$63.2K | 0.24% | 73 |
|
|
2023
Q1 | $651K | Sell |
4,085
-2,391
| -37% | -$381K | 0.29% | 71 |
|
|
2022
Q4 | $1.05M | Buy |
+6,476
| New | +$1.05M | 0.55% | 36 |
|